SG Americas Securities’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
ECM
MCM
CG
TC
SFS
SG Americas Securities's BBH Position: Q4 2017 in Review
SG Americas Securities sold out of VanEck Biotech ETF (BBH) in Q4 2017, closing a stake of 1,753 shares — an estimated $235K sold.
SG Americas Securities first reported a position in BBH in Q2 2014 and held it in 14 quarters. The position peaked at $3M in Q3 2016. 82 funds tracked by Wall St. Rank hold BBH as of Q4 2017.
- SG Americas Securities reported no remaining VanEck Biotech ETF position as of Q4 2017 after selling out during the quarter.
- SG Americas Securities sold 1,753 VanEck Biotech ETF shares in Q4 2017, an estimated $235K.
- SG Americas Securities first reported a position in VanEck Biotech ETF in Q2 2014 and held it in 14 quarters.
- SG Americas Securities's VanEck Biotech ETF position peaked at $3M in Q3 2016.
- 82 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2017.
Based on SG Americas Securities's 13F filing for Q4 2017, filed 24 Jan 2018.